Firefly is rated BUY with a 12-month price target of $53, reflecting a significant discount to fair value after recent share price weakness. FLY's diversified platform now spans launch vehicles, lunar ...
Johnson & Johnson JNJ1.61%increase; up pointing triangle has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline. J&J on ...
June 8 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab said on Monday it will acquire biotech Firefly Bio for $1 billion in cash, as it looks to expand its cancer drug pipeline. Firefly's ...
In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results